Representatives Diana Harshbarger (R-TN-01) and Kevin Hern (R-OK-01) introduced a bill Tuesday in the U.S. House of Representatives to invalidate the FDA’s recently-updated Risk Evaluation and Mitigation Strategy (REMS) of mifepristone, a chemical abortion drug.
Mifepristone is a chemical drug treatment that works together with misoprostol to end a pregnancy through ten weeks gestation, according to the FDA.
Mifepristone is a chemical drug treatment that works together with misoprostol to end a pregnancy through ten weeks gestation, according to the FDA.
